Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.
Identifieur interne : 000320 ( Main/Exploration ); précédent : 000319; suivant : 000321Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.
Auteurs : Naoki Kawamorita [États-Unis] ; Yasuhiro Kaiho [Japon] ; Minoru Miyazato [États-Unis] ; Yoichi Arai [Japon] ; Naoki Yoshimura [États-Unis]Source :
- Neurourology and urodynamics [ 1520-6777 ] ; 2015.
Descripteurs français
- KwdFr :
- Agonistes des récepteurs de la sérotonine (pharmacologie), Animaux, Antagonistes des acides aminés excitateurs (pharmacologie), Femelle, Fluoxétine (analogues et dérivés), Fluoxétine (pharmacologie), Incontinence urinaire d'effort, Norépinéphrine (antagonistes et inhibiteurs), Norépinéphrine (physiologie), Pipérazines (pharmacologie), Quinoxalines (pharmacologie), Rat Sprague-Dawley, Rats, Récepteur de l'AMPA (antagonistes et inhibiteurs), Récepteur de l'AMPA (physiologie), Récepteur de la sérotonine de type 5-HT2B (), Récepteur de la sérotonine de type 5-HT2B (physiologie), Récepteur de la sérotonine de type 5-HT2C (), Récepteur de la sérotonine de type 5-HT2C (physiologie), Réflexe (), Réflexe (physiologie), Urètre (), Urètre (physiologie), Éternuement.
- MESH :
- analogues et dérivés : Fluoxétine.
- antagonistes et inhibiteurs : Norépinéphrine, Récepteur de l'AMPA.
- pharmacologie : Agonistes des récepteurs de la sérotonine, Antagonistes des acides aminés excitateurs, Fluoxétine, Pipérazines, Quinoxalines.
- physiologie : Norépinéphrine, Récepteur de l'AMPA, Récepteur de la sérotonine de type 5-HT2B, Récepteur de la sérotonine de type 5-HT2C, Réflexe, Urètre.
- Animaux, Femelle, Incontinence urinaire d'effort, Rat Sprague-Dawley, Rats, Récepteur de la sérotonine de type 5-HT2B, Récepteur de la sérotonine de type 5-HT2C, Réflexe, Urètre, Éternuement.
English descriptors
- KwdEn :
- Animals, Excitatory Amino Acid Antagonists (pharmacology), Female, Fluoxetine (analogs & derivatives), Fluoxetine (pharmacology), Norepinephrine (antagonists & inhibitors), Norepinephrine (physiology), Piperazines (pharmacology), Quinoxalines (pharmacology), Rats, Rats, Sprague-Dawley, Receptor, Serotonin, 5-HT2B (drug effects), Receptor, Serotonin, 5-HT2B (physiology), Receptor, Serotonin, 5-HT2C (drug effects), Receptor, Serotonin, 5-HT2C (physiology), Receptors, AMPA (antagonists & inhibitors), Receptors, AMPA (physiology), Reflex (drug effects), Reflex (physiology), Serotonin Receptor Agonists (pharmacology), Sneezing, Urethra (drug effects), Urethra (physiology), Urinary Incontinence, Stress.
- MESH :
- chemical , analogs & derivatives : Fluoxetine.
- chemical , antagonists & inhibitors : Norepinephrine, Receptors, AMPA.
- chemical , drug effects : Receptor, Serotonin, 5-HT2B, Receptor, Serotonin, 5-HT2C.
- chemical , pharmacology : Excitatory Amino Acid Antagonists, Fluoxetine, Piperazines, Quinoxalines, Serotonin Receptor Agonists.
- chemical , physiology : Norepinephrine, Receptor, Serotonin, 5-HT2B, Receptor, Serotonin, 5-HT2C, Receptors, AMPA.
- drug effects : Reflex, Urethra.
- physiology : Reflex, Urethra.
- Animals, Female, Rats, Rats, Sprague-Dawley, Sneezing, Urinary Incontinence, Stress.
Abstract
To investigate the role of the glutamatergic pathway and its relationship to noradrenergic and serotonergic pathways in modulation of the urethral continence reflex during sneezing in rats.
DOI: 10.1002/nau.22588
PubMed: 24668912
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000234
- to stream PubMed, to step Curation: 000234
- to stream PubMed, to step Checkpoint: 000234
- to stream Ncbi, to step Merge: 001798
- to stream Ncbi, to step Curation: 001798
- to stream Ncbi, to step Checkpoint: 001798
- to stream Main, to step Merge: 000320
- to stream Main, to step Curation: 000320
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.</title><author><name sortKey="Kawamorita, Naoki" sort="Kawamorita, Naoki" uniqKey="Kawamorita N" first="Naoki" last="Kawamorita">Naoki Kawamorita</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Kaiho, Yasuhiro" sort="Kaiho, Yasuhiro" uniqKey="Kaiho Y" first="Yasuhiro" last="Kaiho">Yasuhiro Kaiho</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai</wicri:regionArea><wicri:noRegion>Sendai</wicri:noRegion></affiliation></author><author><name sortKey="Miyazato, Minoru" sort="Miyazato, Minoru" uniqKey="Miyazato M" first="Minoru" last="Miyazato">Minoru Miyazato</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Arai, Yoichi" sort="Arai, Yoichi" uniqKey="Arai Y" first="Yoichi" last="Arai">Yoichi Arai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai</wicri:regionArea><wicri:noRegion>Sendai</wicri:noRegion></affiliation></author><author><name sortKey="Yoshimura, Naoki" sort="Yoshimura, Naoki" uniqKey="Yoshimura N" first="Naoki" last="Yoshimura">Naoki Yoshimura</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:24668912</idno><idno type="pmid">24668912</idno><idno type="doi">10.1002/nau.22588</idno><idno type="wicri:Area/PubMed/Corpus">000234</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000234</idno><idno type="wicri:Area/PubMed/Curation">000234</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000234</idno><idno type="wicri:Area/PubMed/Checkpoint">000234</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000234</idno><idno type="wicri:Area/Ncbi/Merge">001798</idno><idno type="wicri:Area/Ncbi/Curation">001798</idno><idno type="wicri:Area/Ncbi/Checkpoint">001798</idno><idno type="wicri:Area/Main/Merge">000320</idno><idno type="wicri:Area/Main/Curation">000320</idno><idno type="wicri:Area/Main/Exploration">000320</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.</title><author><name sortKey="Kawamorita, Naoki" sort="Kawamorita, Naoki" uniqKey="Kawamorita N" first="Naoki" last="Kawamorita">Naoki Kawamorita</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Kaiho, Yasuhiro" sort="Kaiho, Yasuhiro" uniqKey="Kaiho Y" first="Yasuhiro" last="Kaiho">Yasuhiro Kaiho</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai</wicri:regionArea><wicri:noRegion>Sendai</wicri:noRegion></affiliation></author><author><name sortKey="Miyazato, Minoru" sort="Miyazato, Minoru" uniqKey="Miyazato M" first="Minoru" last="Miyazato">Minoru Miyazato</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Arai, Yoichi" sort="Arai, Yoichi" uniqKey="Arai Y" first="Yoichi" last="Arai">Yoichi Arai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Urology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai</wicri:regionArea><wicri:noRegion>Sendai</wicri:noRegion></affiliation></author><author><name sortKey="Yoshimura, Naoki" sort="Yoshimura, Naoki" uniqKey="Yoshimura N" first="Naoki" last="Yoshimura">Naoki Yoshimura</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh</wicri:cityArea></affiliation></author></analytic><series><title level="j">Neurourology and urodynamics</title><idno type="eISSN">1520-6777</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Excitatory Amino Acid Antagonists (pharmacology)</term><term>Female</term><term>Fluoxetine (analogs & derivatives)</term><term>Fluoxetine (pharmacology)</term><term>Norepinephrine (antagonists & inhibitors)</term><term>Norepinephrine (physiology)</term><term>Piperazines (pharmacology)</term><term>Quinoxalines (pharmacology)</term><term>Rats</term><term>Rats, Sprague-Dawley</term><term>Receptor, Serotonin, 5-HT2B (drug effects)</term><term>Receptor, Serotonin, 5-HT2B (physiology)</term><term>Receptor, Serotonin, 5-HT2C (drug effects)</term><term>Receptor, Serotonin, 5-HT2C (physiology)</term><term>Receptors, AMPA (antagonists & inhibitors)</term><term>Receptors, AMPA (physiology)</term><term>Reflex (drug effects)</term><term>Reflex (physiology)</term><term>Serotonin Receptor Agonists (pharmacology)</term><term>Sneezing</term><term>Urethra (drug effects)</term><term>Urethra (physiology)</term><term>Urinary Incontinence, Stress</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agonistes des récepteurs de la sérotonine (pharmacologie)</term><term>Animaux</term><term>Antagonistes des acides aminés excitateurs (pharmacologie)</term><term>Femelle</term><term>Fluoxétine (analogues et dérivés)</term><term>Fluoxétine (pharmacologie)</term><term>Incontinence urinaire d'effort</term><term>Norépinéphrine (antagonistes et inhibiteurs)</term><term>Norépinéphrine (physiologie)</term><term>Pipérazines (pharmacologie)</term><term>Quinoxalines (pharmacologie)</term><term>Rat Sprague-Dawley</term><term>Rats</term><term>Récepteur de l'AMPA (antagonistes et inhibiteurs)</term><term>Récepteur de l'AMPA (physiologie)</term><term>Récepteur de la sérotonine de type 5-HT2B ()</term><term>Récepteur de la sérotonine de type 5-HT2B (physiologie)</term><term>Récepteur de la sérotonine de type 5-HT2C ()</term><term>Récepteur de la sérotonine de type 5-HT2C (physiologie)</term><term>Réflexe ()</term><term>Réflexe (physiologie)</term><term>Urètre ()</term><term>Urètre (physiologie)</term><term>Éternuement</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Fluoxetine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Norepinephrine</term><term>Receptors, AMPA</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptor, Serotonin, 5-HT2B</term><term>Receptor, Serotonin, 5-HT2C</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Excitatory Amino Acid Antagonists</term><term>Fluoxetine</term><term>Piperazines</term><term>Quinoxalines</term><term>Serotonin Receptor Agonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Norepinephrine</term><term>Receptor, Serotonin, 5-HT2B</term><term>Receptor, Serotonin, 5-HT2C</term><term>Receptors, AMPA</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Fluoxétine</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Norépinéphrine</term><term>Récepteur de l'AMPA</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Reflex</term><term>Urethra</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Agonistes des récepteurs de la sérotonine</term><term>Antagonistes des acides aminés excitateurs</term><term>Fluoxétine</term><term>Pipérazines</term><term>Quinoxalines</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Norépinéphrine</term><term>Récepteur de l'AMPA</term><term>Récepteur de la sérotonine de type 5-HT2B</term><term>Récepteur de la sérotonine de type 5-HT2C</term><term>Réflexe</term><term>Urètre</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Reflex</term><term>Urethra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Rats</term><term>Rats, Sprague-Dawley</term><term>Sneezing</term><term>Urinary Incontinence, Stress</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Femelle</term><term>Incontinence urinaire d'effort</term><term>Rat Sprague-Dawley</term><term>Rats</term><term>Récepteur de la sérotonine de type 5-HT2B</term><term>Récepteur de la sérotonine de type 5-HT2C</term><term>Réflexe</term><term>Urètre</term><term>Éternuement</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To investigate the role of the glutamatergic pathway and its relationship to noradrenergic and serotonergic pathways in modulation of the urethral continence reflex during sneezing in rats.</div></front></TEI><affiliations><list><country><li>Japon</li><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Kawamorita, Naoki" sort="Kawamorita, Naoki" uniqKey="Kawamorita N" first="Naoki" last="Kawamorita">Naoki Kawamorita</name></region><name sortKey="Miyazato, Minoru" sort="Miyazato, Minoru" uniqKey="Miyazato M" first="Minoru" last="Miyazato">Minoru Miyazato</name><name sortKey="Yoshimura, Naoki" sort="Yoshimura, Naoki" uniqKey="Yoshimura N" first="Naoki" last="Yoshimura">Naoki Yoshimura</name></country><country name="Japon"><noRegion><name sortKey="Kaiho, Yasuhiro" sort="Kaiho, Yasuhiro" uniqKey="Kaiho Y" first="Yasuhiro" last="Kaiho">Yasuhiro Kaiho</name></noRegion><name sortKey="Arai, Yoichi" sort="Arai, Yoichi" uniqKey="Arai Y" first="Yoichi" last="Arai">Yoichi Arai</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000320 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000320 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24668912
|texte= Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24668912" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |